Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
61-75 of 2253 results
Novartis mulls options including IPO, spinoff for Alcon eye care unit
By PBR Staff Writer
Swiss pharma giant Novartis has said that it is considering options including an IPO or spin-off of its eye care division.
Production & Manufacturing > Manufacturing > News
Merck, Bristol-Myers and Ono Pharmaceutical agree to settle Keytruda patent suit
By PBR Staff Writer
Merck has agreed to pay $625m and royalties to Bristol-Myers Squibb and Ono Pharmaceutical to settle patent litigation over its cancer drug Keytruda.
Production & Manufacturing > Manufacturing > News
Lilly to buy CoLucid Pharmaceuticals for $960m
By PBR Staff Writer
Eli Lilly and Company has agreed to acquire migraine drug developer CoLucid Pharmaceuticals for about $960m.
Production & Manufacturing > Manufacturing > News
US appeals court upholds Eli Lilly's patent on Alimta cancer drug
By PBR Staff Writer
Eli Lilly and Company has received a favorable court ruling in the US regarding the vitamin regimen patent for its cancer drug Alimta.
Production & Manufacturing > Manufacturing > News
Takeda to buy Ariad Pharmaceuticals for $5.2bn
By PBR Staff Writer
Japan's Takeda Pharmaceutical has agreed to acquire US cancer drug maker Ariad Pharmaceuticals in a transaction worth about $5.2bn.
Production & Manufacturing > Manufacturing > News
Regeneron, Sanofi to appeal US court’s ruling in Praulent patent case
By PBR Staff Writer
Regeneron Pharmaceuticals and Sanofi will appeal the ruling of a US federal judge in a patent infringement case that prevents the duo from marketing, selling or manufacturing of their cholesterol drug Praulent (alirocumab) injection in the US.
Production & Manufacturing > Manufacturing > News
Sanofi, Boehringer complete swap of animal, consumer health assets in most markets
By PBR Staff Writer
Sanofi and Boehringer Ingelheim have completed the exchange of their respective animal health and consumer healthcare businesses in most markets.
Production & Manufacturing > Manufacturing > News
Zydus acquires six brands from MSD in India
By PBR Staff Writer
India based Zydus Cadila’s subsidiary Zydus Healthcare has acquired six brands from MSD related to the women’s health, men’s health, cardiovascular and wound management areas for an undisclosed sum.
Production & Manufacturing > Manufacturing > News
AstraZeneca completes sale of small molecule antibiotics business to Pfizer
By PBR Staff Writer
AstraZeneca has completed the sale of its small molecule antibiotics business to Pfizer for $550m.
Production & Manufacturing > Manufacturing > News
Genticel and Genkyotex sign agreement to merge
Swiss company Genticel and Genkyotex have signed an agreement to enter into strategic combination.
Production & Manufacturing > Manufacturing > News
Fluor to build Novo Nordisk's $2bn API manufacturing facility in North Carolina
Novo Nordisk has awarded Fluor an engineering, procurement, construction and construction management contract for its new $2bn diabetes Active Pharmaceutical Ingredient (API) manufacturing facility in Clayton, North Carolina, US.
Production & Manufacturing > Manufacturing > News
Actavis UK accused of breaking competition law by charging unfair prices
By PBR Staff Writer
The UK’s Competition and Markets Authority (CMA) has accused drug maker Actavis UK of overcharging the NHS for a lifesaving drug by increasing its price by more than 12,000%.
Production & Manufacturing > Manufacturing > News
Merck's subsidiary wins $2.5bn patent verdict against Gilead Sciences
A jury in the US District Court for the District of Delaware ordered Gilead Sciences to pay $2.54bn in damages to Merck's subsidiary Idenix Pharmaceuticals for infringing its patents in developing hepatitis C drugs.
Production & Manufacturing > Manufacturing > News
Sanofi reportedly in talks to buy Swiss drug maker Actelion
By PBR Staff Writer
French drugmaker Sanofi is reportedly in negotiations with Actelion after US healthcare group Johnson & Johnson abandoned its efforts to acquire the Swiss biotechnology firm.
Production & Manufacturing > Manufacturing > News
GSK to open new global vaccines R&D center in Maryland, US
GSK is opening a new global vaccines research and development (R&D) center in Rockville, Maryland, US.
Production & Manufacturing > Manufacturing > News
61-75 of 2253 results